Menu
Drug-delivering contact lenses are innovative lenses embedded with medication that release controlled doses directly to the eye, offering targeted treatment for various eye conditions and improving patient convenience.
Drug-delivering contact lenses work by embedding a drug-loaded polymer into the lens material. As the lens sits on the eye, the drug is gradually released into the tear film, providing sustained medication delivery over time. This controlled release ensures targeted treatment while reducing side effects compared to traditional eye drops.
Drug-delivering contact lenses offer targeted, sustained medication, improve patient compliance, reduce side effects, and eliminate the need for frequent eye drops or ointments.
Amnion-based dissolvable contact lenses are made from amniotic membrane material, designed to dissolve and release healing properties, promoting faster recovery from eye injuries and treating various ocular surface conditions.
Amnion-based dissolvable contact lenses utilize the natural healing properties of the amniotic membrane, rich in growth factors and anti-inflammatory proteins. Once applied, the lens dissolves over time, releasing these bioactive substances to the eye’s surface, accelerating tissue regeneration and reducing inflammation, making them ideal for treating ocular surface disorders.
Amnion-based dissolvable contact lenses promote faster healing, reduce inflammation, enhance tissue regeneration, and offer a convenient, non-invasive treatment for various eye surface injuries and conditions.
A combination amniotic membrane and dissolvable biopolymer contact lens designed to treat corneal wound from trauma, surgery or dry eye. The lens is designed to reabsorb over a 3-5 period without further clinical intervention. The product uses existing reimbursement codes.
Diopter Technologies holds a strong intellectual property foundation. They are inviting investors and collaborators to help reshape the future of ophthalmology and improve the lives of millions of patients globally.